A clinicopathological study of gestational trophoblastic disease in a tertiary care centre of southern Assam


  • Sailendra K. Thakuria Department of Pathology, Silchar Medical College and Hospital, Silchar, Assam, India
  • Monoj K. Deka Department of Pathology, Silchar Medical College and Hospital, Silchar, Assam, India
  • Shah A. Sheikh Department of Pathology, Silchar Medical College and Hospital, Silchar, Assam, India




Beta hCG, Choriocarinoma, Gestational trophoblastic disease, Histopathology, Hydatiform mole, Invasive mole


Background: Gestational trophoblastic disease (GTD) covers a wide spectrum of benign and malignant conditions that arise from pregnancies with abnormal trophoblastic tissue development. It is a source of significant morbidity as well as increased risk of mortality from their complications if not identified and treated early enough. Our study aimed at the various clinicopathological features of GTDs along with their prevalence in a tertiary care centre.

Methods: It was a retrospective cross-sectional study conducted over a period of 3 years from January 2017 to December 2019. All GTD cases were retrieved from department registries and analysed.

Results: Out of 60 diagnosed cases of GTDs, 57 cases (95%) were Hydatiform mole. Invasive mole and choriocarcinoma were 2 cases (3%) and 1 cases (2%) respectively. Age ranged from 18-37 years. The most commonly affected age group was 20-25 years with 33 cases (55%). Most cases were presented in the first trimester presenting with bleeding per vagina. The majority of GTD cases belonged to blood group A and 50,000-<1,00,000 mlU/mL beta HCG level.

Conclusions: Histopathological examination is helpful for confirmation of diagnosis.It is very important to follow up of such patients for early diagnosis of malignant trophoblastic tumors.


Dilip K, Pandey Ralph S, Freedman, Vicki VB. Gestational trophoblastic disease. Obst Gynec Clinics North Am.1996;23:2.

Hammond CB. Gestational trophoblastic neoplasms: history of the current understanding. Obst and Gynec clinics of North America. 1988;15(3):435-41.

Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reproductive Med. 1994;39(3):155-62.

Lurain JR. Gestational trophoblastic disease I: Epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obst Gynec. 2010;203(6):531-9.

Berkowitz RS, Goldstein DP, Bernstein MR. Natural history of partial molar pregnancy. Obst Gynec. 1985;66(5):677-81.

Azab MB, Theodore C, Droz JP, Amiel JL, Pejovic MH, George M, Bellet D, Michel G. Prognostic factors in gestational trophoblastic tumors. A multivariate analysis. Cancer. 1988;62(3):585-92.

Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. The Lancet. 2010;376(9742):717-29.

Deep JP, Sedhai LB, Napit J, Pariyar J. Gestational trophoblastic disease. J of Chitwan Medical College. 2013;3(2):4-11.

Yakasai I, Abubakar I, Eze Y. Gestational trophoblastic diseases in a teaching hospital in northern, Nigeria. American J of BioScience. 2015;3(1):7-10.

Agrawal N, Sagtani RA, Budhathoki SS, Pokharel HP. Clinico-epidemiological profile of molar pregnancies in a tertiary care centre of Eastern Nepal: A retrospective review of medical records. Gynecologic oncology Res and practice. 2015;2(1):1-7.

Koirala A, Khatiwada P, Giri A, Kandel P, Regmi M, Upreti D. The demographics of molar pregnancies in BPKIHS. Kathmandu University Medical J. 2011;9(4):298-300.

Sekharan P, Shreedevi NS, Paily VP. Hydatidiform mole in calicut, India. InProceedings of the XII world congress on gestational trophoblastic diseases. Boston. 2003;8:27-9.

Jagtap SV, Aher V, Gadhiya S, Jagtap SS. Gestational trophoblastic disease-Clinicopathological study at tertiary care hospital. J Clin Diagnostic Res. 2017;11(8):27.

Mayun AA, Rafindadi AH, Shehu MS. Pathomorphology of molar gestation in Zaria. Nigerian Medical J. 2010;51(1):1.

Taboo ZA. A prospective study of gestational trophoblastic disease in Al-Mosul City. Iraqi Postgraduate Med J. 2013;12:268-76.

Fatima M, Kasi PM, Baloch SN, Kassi M, Marri SM, Kassi M. Incidence, management, and outcome of molar pregnancies at a tertiary care hospital in Quetta, Pakistan. Int Scholarly Res Notices. 2011;2011.

Berkowitz RS, Goldstein DP, Berck JS. Gestational trophoblastic neoplasm. Philadelphia, Lipincott, Williams and Wilkins, 2002;1353-74.

Parazzini F, Vecchia C, Franceschi S, Pampallona S, Decarli A, Mangili G. ABO blood-groups and the risk of gestational trophoblastic disease. Tumori J. 1985;71(2):123-6.

Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003;46(3):541-56.




How to Cite

Thakuria, S. K., Deka, M. K., & Sheikh, S. A. (2021). A clinicopathological study of gestational trophoblastic disease in a tertiary care centre of southern Assam. International Journal of Research in Medical Sciences, 9(4), 1169–1173. https://doi.org/10.18203/2320-6012.ijrms20211370



Original Research Articles